My Account
Log in Registration
All
Cart
Highlights
Fiction Books
Non-Fiction Books
Children's Books
Rare Books
Music
DVD & Blu-Ray
Video Games
Category
Wishlists
Cart
All
Free Shipping in the UK
Trustpilot
Proud to be B-Corp

Bone Cancer Dominique Heymann (Professor, Faculty of Medicine, University of Nantes Head of Pathophysiology of Bone Resorption and Therapy of Primitive Bone Tumors, INSERM, Nantes, France)

Bone Cancer By Dominique Heymann (Professor, Faculty of Medicine, University of Nantes Head of Pathophysiology of Bone Resorption and Therapy of Primitive Bone Tumors, INSERM, Nantes, France)

Bone Cancer by Dominique Heymann (Professor, Faculty of Medicine, University of Nantes Head of Pathophysiology of Bone Resorption and Therapy of Primitive Bone Tumors, INSERM, Nantes, France)

Reviews:
£166.09
New RRP £196.00
Condition - New
Only 2 left
New

Bone Cancer Summary

Bone Cancer: Bone Sarcomas and Bone Metastases From Bench to Bedside by Dominique Heymann (Professor, Faculty of Medicine, University of Nantes Head of Pathophysiology of Bone Resorption and Therapy of Primitive Bone Tumors, INSERM, Nantes, France)

Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside, Third Edition comprehensively investigates key discoveries in the field of bone biology. New aspects of bone cancer biology are treated in new chapters covering exosomes, autophagy, and metabolism. These have led to the development of entirely new areas for investigation, such as therapies which combine surgery and biological approaches. The Third Edition expands on the original overview of bone cancer development (physiology and pathophysiology), with 40% new material. Each chapter has been written by internationally recognized specialists on the bone cancer microenvironment, bone metastases, osteoclast biology in bone cancer, proteomics, bone niche, circulating tumor cells, and clinical trials. Given the global prevalence of breast and prostate cancers, knowledge of bone biology has become essential for everyone within the medical and cancer research communities. Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside continues to offer the only translational reference to cover all aspects of primary bone cancer and bone metastases. This revision opens the door to myeloma with two short chapters dedicated to this bone-associated disease.

Bone Cancer Reviews

Praise for the Previous Editions: "...a comprehensive description of bone tumors from basic to clinical aspects by the most recent data available...specifically useful to medical students and scientists, health professionals, researchers and teachers working in the osteo-articular field." --Anticancer Research "Reviewing the current advances in the progression and therapeutic approaches to bone cancer is an extremely challenging task. Bone cancer is not a single disease; rather, it is a field comprising a diverse and complex range of malignancies, from primary bone tumors of stromal cell origin, to hematopoietic malignancies and secondary metastatic bone disease. Dominique Heymann has assembled an exciting, comprehensive and up-to-date series of reviews contributed by experts in the basic and clinical aspects of bone research. In the past decade, our understanding of cancers involving bone has increased tremendously, underpinned by advances in the cellular, molecular and biochemical mechanisms of bone cell interactions in health and disease, together with advances in genetics, diagnostics, imaging and therapeutic strategies. All these aspects are covered in this timely volume, which will galvanize further cooperative efforts in the coming years between basic researchers, oncologists and pathologists towards understanding the causes of different bone cancers and translating this knowledge into the clinic." --Agi E. Grigoriadis, PhD, Departments of Craniofacial Development and Orthodontics, King's College London, United Kingdom "Our understanding of bone biology and diseases has strikingly progressed in the last decade. In parallel, the processes that lead to various forms of cancer have been further unraveled and the mechanisms leading to metastatic spread further explored. In this book, Dr. Heymann has gathered some of the world experts on these subjects to explore the cutting edge where these fields merge in the context of bone cancer and metastasis, their pathophysiology, diagnosis and treatment. This encompassing book will undoubtedly meet the needs of residents and fellows as well as expert clinicians and scientists." --Roland Baron, Professor, Harvard Medical School, Boston MA, USA

About Dominique Heymann (Professor, Faculty of Medicine, University of Nantes Head of Pathophysiology of Bone Resorption and Therapy of Primitive Bone Tumors, INSERM, Nantes, France)

Dominique Heymann studied cell biology, biochemistry and immunology in INSERM (French NIH) unit 211 at the University of Nantes and received his Ph.D. in 1995. He was appointed Associate Professor in 2001 in the Department of Histology and Embryology. In 2009, he was awarded a personal Chair of Histology and Embryology.Currently he is the Quality Control Manager of the Tissue Bank and Gene and Cellular Therapy Unit at Nantes Hospital. He heads a laboratory research group (INSERM UMR 957) of 65 people at the Faculty of Medicine, where the pathogenesis of primary bone tumours, and more specifically, the role of bone microenvironment (osteoclasts, mesenchymal stem cells, OPG/RANK/RANKL, IL-6 and MCSF cytokine family) in tumour growth is studied.In 2006, Dominique Heymann won the Paul Mathieu prize from the National Academy of Medicine for his work entitled From the osteolytic process associated to primary bone tumors to the development of bi-therapies for osteosarcoma. He was on the national scientific advisory board of INSERM (2008-2012) and is now Co-Chairman of INSERM scientific commission n5 (Physiology and pathophysiology of endocrine, bone, skin and gastrointestinal tissues). He has authored approximately 180 publications in peer- reviewed journals, more than 300 abstracts and 20 book chapters. He is also Associate Editor of Life Sciences, Academic Editor of PLoS ONE, Editor-in-Chief of the Open Bone Journal and serves on the Editorial Board of Current Medicine Chemistry, European Journal of Pharmacology, and Journal of Bone Oncology.

Table of Contents

Epidemiology of Bone Cancer 1. Osteoarchaeology: lessons to learn from the past 2. Epidemiology of primary bone tumors and economical aspects of bone metastases Models of Bone Cancers and Technical Aspects Animal Models 3. Animal models of bone sarcomas 4. In vivo models used in studies of bone metastaes 5. Zebrafish models for studying bone tumors Mathematic models and machine learning 6. Use of machine learning in bone cancers 7. Artifical intelligence for bone cancer imaging Preparation of tissue samples: technical aspects 8. Technical aspects: how do we best prepare bone samples for proper histological analysis? Bone Microenvironment and Bone Cancer Bone niche 9. Bone niche and bone metastases 10. Bone: a fertil soil for tumor development 11. Osteomimicry: old concepts and new findings Dialog between cancer cells and bone cells 12. Role of mesenchymal stem cells in bone cancers, initiation, propagation and metastasis 13. Technical approaches for studying the communications between osteocytes and cancer cells 14. Osteocytes and bone cancers 15. Immune functions of osteoclasts: new insights for bone cancers 16. Immune infiltrate in bone sarcomas 17. Macrophages and pathophysiology of bone cancers Mediators of cell communications 18. Growth factors, cytokines and pediatric malignant primary bones tumors 19. The role of NFkB in bone cancer 20. TGF-beta and bone cancers: a specific focus 21. Extracellular vesicles, tumor growth and metastatic process 22. Connexin43 and development of primary bone tumors : osteosarcoma and Ewings sarcoma 23. The role of endocannabinoid system in bone cancer Metabolism 24. Impact of the microenvironment acidosis on bone cancers 25. Hypoxic niche and bone cancers 26. Metabolism and bone cancers Bone Tumor Heterogeneity, Plasticity and Biomarkers Heterogeneity and plasticity 27. EMT process in bone metastasis 28. Cancer stem cells and clonal evolution in bone sarcomas 29. Dormancy in cancer bone metastasis Biomarkers 30. Bone Remodelling Markers and Bone Cancer 31. Epigenetic Heterogeneity in Primary Bone Cancers 32. miRNA implication in therapeutic resistance and metastatic dissemination of bone-associated tumors 33. MicroRNAs and bone metastasis: how small RNAs regulate secondary tumour formation and progression in the skeleton 34. Long-non coding RNA and bone sarcoma 35. Liquid biopsy and circulating tumor cells in bone sarcomas: identification of new biomarkers and analysis of the tumor heterogeneity 36. Disseminated tumor cells in bone marrow of cancer patients II. PRIMARY BONE TUMORS Biological aspects 37. Cytogenetics of bone sarcomas 38. Genetic aspects of primary bone tumors 39. Markers of bone sarcomas 40. Molecular pathology of osteosarcoma 41. Genomic and proteomic profiling of osteosarcoma 42. Ewing sarcoma family of tumors 43. Molecular aspects of Ewing sarcomas 44. Osteoclast-rich lesions: a clinical and molecular overview 45. Biology of cartilage tumor family Clinical aspects and Perspectives Imaging 46. Imaging of bone sarcomas Therapeutic approaches 47. Current therapeutic approaches of bone sarcomas 48. Surgical approaches of bone sarcomas: Margins and clinical impact 49. Apoptosis and drug resistance in malignant bone tumors: impact on the clinical practices 50. Chondrosarcoma of Bone: Diagnosis and Therapy 51. Radiotherapy and Primary bone tumors 52. New therapeutic advances of bone sarcomas III. BONE METASTASES Biological aspects 53. The histopathology of skeletal Metastases 54. Indentification of new therapeutic targets of bone cancers by proteomic strategies Clinical aspects and Perspectives Imaging 55. Interventional radiologic techniques in management of bone tumors 56. Diagnosis of bone metastases in urological malignancies an update Bone pain 57. Mechanisms and management of bone cancer pain 58. Involvement of sympathic nerves in bone mestastasis 59. Pain control with palliative radiotherapy in patients with bone metastases 60. Palliative care of bone metastases Therapeutic approaches 61. Radiotherapy of bone metastases 62. Cellular and molecular actions of bisphosphonates: therapeutic interest in tumor-associated bone diseases 63. Bone-Targeted agents and skeletal-related events in breast cancer patients with bone metastases 64. Bone metastases current status of bone-targeted treatments 65. Therapies of bone metastases in castration-resistant prostate cancer 66. Therapy with bone-targeting radiopharmaceuticals 67. Therapeutic approaches of bone metastases associated with breast cancer MYELOMA: A BONE ASSOCIATED DISEASE 68. Biological relationship between bone and myeloma cells 69. Recent therapeutic approaches in myeloma

Additional information

NGR9780128216668
9780128216668
0128216662
Bone Cancer: Bone Sarcomas and Bone Metastases From Bench to Bedside by Dominique Heymann (Professor, Faculty of Medicine, University of Nantes Head of Pathophysiology of Bone Resorption and Therapy of Primitive Bone Tumors, INSERM, Nantes, France)
Dominique Heymann (Professor, Faculty of Medicine, University of Nantes Head of Pathophysiology of Bone Resorption and Therapy of Primitive Bone Tumors, INSERM, Nantes, France)
New
Hardback
Elsevier Science Publishing Co Inc
2021-09-22
1078
N/A
Book picture is for illustrative purposes only, actual binding, cover or edition may vary.
This is a new book - be the first to read this copy. With untouched pages and a perfect binding, your brand new copy is ready to be opened for the first time

Customer Reviews - Bone Cancer